Safety and Immunogenicity of MVA85A Prime and Bacille Calmette-Guerin Boost Vaccination (MVA(TB)029)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01650389
Recruitment Status : Completed
First Posted : July 26, 2012
Last Update Posted : September 30, 2015
Medical Research Council
Wellcome Trust
Department for International Development, United Kingdom
University of Oxford
University of Stellenbosch
Oxford-Emergent Tuberculosis Consortium
Information provided by (Responsible Party):
Mark Hatherill, University of Cape Town